Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$504K Sell
5,351
-185
-3% -$18.5K ﹤0.01% 810
2025
Q4
$547K Buy
5,536
+46
+0.8% +$4.45K ﹤0.01% 695
2025
Q3
$466K Buy
+5,490
New +$434K ﹤0.01% 734
2024
Q3
Sell
-5,687
Closed -$345K 1067
2024
Q2
$345K Sell
5,687
-33
-0.6% -$1.87K ﹤0.01% 747
2024
Q1
$326K Buy
+5,720
New +$343K ﹤0.01% 886
2020
Q1
Sell
-4,422
Closed -$386K 864
2019
Q4
$386K Sell
4,422
-192
-4% -$16.4K ﹤0.01% 601
2019
Q3
$343K Buy
4,614
+104
+2% +$8.41K ﹤0.01% 778
2019
Q2
$383K Sell
4,510
-236
-5% -$18.9K ﹤0.01% 690
2019
Q1
$408K Buy
+4,746
New +$386K ﹤0.01% 658
2017
Q1
Sell
-5,590
Closed -$561K 783
2016
Q4
$561K Buy
5,590
+365
+7% +$35.6K ﹤0.01% 314
2016
Q3
$493K Buy
+5,225
New +$440K ﹤0.01% 276

Other funds holding INCY

ALPS Advisors's INCY Position: Q1 2026 in Review

ALPS Advisors reduced its Incyte (INCY) stake by 3.3% in Q1 2026, selling an estimated $18.5K and leaving 5,351 shares worth $504K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

ALPS Advisors first reported a position in INCY in Q3 2016 and has held it in 11 quarters since. The position peaked at $561K in Q4 2016. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • ALPS Advisors held 5,351 shares of Incyte worth $504K as of Q1 2026.
  • ALPS Advisors sold 185 Incyte shares in Q1 2026, an estimated $18.5K.
  • Incyte made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #810 holding.
  • ALPS Advisors first reported a position in Incyte in Q3 2016 and has held it in 11 quarters since.
  • ALPS Advisors's Incyte position peaked at $561K in Q4 2016.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.